Agnes Natukunda

First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: Pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials

Robin Young, Agnes Natukunda, Saskia Litière et al. · European Journal of Cancer · 2014 · 125 citations

Oncology, Eleven European Organisation, Metronomic Therapy +8

Urban-rural differences in immune responses to mycobacterial and tetanus vaccine antigens in a tropical setting: A role for helminths?

Joyce Kabagenyi, Agnes Natukunda, Jacent Nassuuna et al. · Parasitology International · 2020 · 25 citations · Full text

Effect of intensive treatment for schistosomiasis on immune responses to vaccines among rural Ugandan island adolescents: randomised controlled trial protocol A for the ‘POPulation differences in VACcine responses’ (POPVAC) programme

Gyaviira Nkurunungi, Ludoviko Zirimenya, Jacent Nassuuna et al. · BMJ Open · 2021 · 21 citations · Full text

Population differences in vaccine responses (POPVAC): scientific rationale and cross-cutting analyses for three linked, randomised controlled trials assessing the role, reversibility and mediators of immunomodulation by chronic infections in the tropics

Gyaviira Nkurunungi, Ludoviko Zirimenya, Agnes Natukunda et al. · BMJ Open · 2020 · 19 citations · Full text

Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial

Anne Wajja, Beatrice Nassanga, Agnes Natukunda et al. · The Lancet Infectious Diseases · 2023 · 17 citations · Full text